Skip to main content
Premium Trial:

Request an Annual Quote

BGI Adopts Force10 Networks' Ethernet Switching Solutions to Handle Sequencing Computation


The Beijing Genomics Institute at Shenzhen has deployed Force10 Networks' 10-gigabit ethernet switching solutions to support the computational infrastructure for its sequencing activities, Force10 said this week.

The company said that BGI has adopted its C300 and C150 chassis-based switches and its S2410 and S50 access switches to distribute "large amounts of compute resources and network traffic" resulting from its sequencing capacity.

BGI currently runs 137 Illumina HiSeq 2000 systems, 27 Life Technologies SOLiD systems, and more than 100 Sanger sequencers.

All the switches deployed at the institute run the Force10 Operating System software, which the company said is built to "streamline network management, reduce unplanned downtime related to operational error, and lower the total cost of network ownership."

According to the technology firm, its tools "[provide] the high performance, low latency, and scalability" needed for complex computation. As an example, the S2410, a 24-port 10 GbE switch with a switching latency of less than 300 nanoseconds, "provides rapid and predictable performance required to ... move data out to the network edge without impacting computing performance," the company said.

Fang Lin, administrator of BGI Shenzhen's computation platform, said that Force10's products provide "a practical solution for the demanding requirements of our servers, memory, and network" and that they "have contributed to the successful implementation of many large-scale gene sequencing projects."

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.